Simultaneous Cochlear Implantation and Salvage Translabyrinthine Resection of Vestibular Schwannoma after Radiotherapy.
Document Type
Article
Publication Date
6-1-2023
Publication Title
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
Abstract
OBJECTIVE: To report on the novel use of simultaneous cochlear implantation (CI) during salvage translabyrinthine resection of vestibular schwannoma (VS) after failed stereotactic radiosurgery (SRS).
PATIENT: A 52-year-old woman presented with a medium-sized right VS. She experienced continued tumor growth despite previous SRS, resulting in medial extension beyond the internal auditory canal into the cerebellopontine angle. Associated symptoms included asymmetrical right moderate to severe sensorineural hearing loss, poor word recognition, tinnitus, and dizziness.
INTERVENTION: Simultaneous CI with translabyrinthine VS resection.
MAIN OUTCOME MEASURE: CI-aided pure-tone averages.
RESULTS: After 4 months of device use, CI-aided speech audiometry revealed hearing thresholds in the normal range, with a four-tone pure-tone, average of 16.3 dB. Speech perception with consonant-nucleus-consonant testing in the CI-only condition was 46%, representing a 12% improvement compared with preoperatively. Tinnitus and dizziness burden were subjectively reduced.
CONCLUSIONS: Despite challenges inherent to second procedures after radiotherapy failure, successful CI outcomes can be achieved. The current study demonstrates the feasibility of simultaneous CI during salvage VS resection after SRS. A larger study should be undertaken to further substantiate these preliminary findings.
Volume
44
Issue
5
First Page
502
Last Page
506
Recommended Citation
Choi JS, Fritz CG, Babu KC, Fan CJ, Babu SC. Simultaneous Cochlear Implantation and Salvage Translabyrinthine Resection of Vestibular Schwannoma after Radiotherapy. Otol Neurotol. 2023 Jun 1;44(5):502-506. doi: 10.1097/MAO.0000000000003868. PMID: 37167449.
DOI
10.1097/MAO.0000000000003868
ISSN
1537-4505
PubMed ID
37167449